Portal Home For reimbursement information regarding other Centocor Ortho Biotech Inc. products, please click here.
PROCRITline.com Reimbursement Excellence Centocor Ortho Biotech Inc.
Introduction Commercial Payer Prior Authorization Medicare Part D Prior Authorization Please see full Prescribing Information, including Boxed WARNINGS, for PROCRIT® (Epoetin alfa) Medicare Guideline Archives Medicare Guideline Update Table CMS 1450 / UB-04

State Medicare Guidelines / CMS 1500
Select



State Medicare Guidelines / CMS 1500

California Printable Version


Summary - Part A  Summary - Part B  

National Coverage Determination

Local Coverage Determinations / Supporting Documentation:
MAC Part A - MAC Part B

CMS 1500 Examples
Initial Claims: Oncology 1 Subsequent Claims: Oncology 2
Nephrology 1 Nephrology 2
AZT/HIV 1 AZT/HIV 2
Surgery 1 Surgery 2
Payers

Part-A
Palmetto GBA

Part-B
Palmetto GBA

Carrier/FI/MAC Changes




Please refer to the National Coverage Determination (NCD) for additional information that may supercede the Medicare guidelines provided by your local Medicare Carrier, Fiscal Intermediary, or Medicare Administrative Contractor (MAC).



Summary - Part A - Updated August 01, 2010

For additional information on Medicare covered indications for your specific state, please see the appropriate Part A Local Coverage Determinations/Supporting Documentation which may be accessed through the link above or by
clicking here - Part A.

Your state has two Medicare contractors which process claims for Part A providers. If you use WPS (formerly Mutual of Omaha), please select it now. WPS If you do not use WPS, the Medicare guideline summary is below.

Indication ICD-9-CM HCPCS Starting Labs Ending Labs GFR/Serum Creatinine Allowable Dosage Post Chemo
Cancer (chemo) 284.89 or 285.3 and V58.11 or V58.12 and 140.0-149.9, 150.0-159.9, 160.0-165.9, 170.0-176.9, 179-189.9, 190.0-199.1, 199.2, 200.00-202.98, 203.00-203.81, 203.82, 204.00-204.91, 204.92, 209.00-209.30, 209.31, 209.32, 209.33, 209.34, 209.35, 209.36, 233.30, 233.31, 233.32, 233.39, 235.0-235.9, 236.0-236.99, 237.0-237.9, 238.0, 238.1, 238.2, 238.3, 238.5, 238.6, 238.77, 238.79-238.9, 239.0-239.8, 239.81, 239.89, 239.9 or 273.3
Link
J0885
Link
HCT < 30% or Hb < 10 g/dL
Link
HCT 30% or Hb 10 g/dL
Link
SC: Not Applicable

GFR: Not Applicable
Starting dose 150 U/kg 3x/wk
Link
8 weeks
Link
AIDS/AZT 284.89 and 042 or 079.53
Link
J0885
Link
Not Stated HCT 30-36% or Hb 10-12 g/dL
Link
SC: Not Applicable

GFR: Not Applicable
Not Stated Not Applicable
Renal 285.21 and 403.00, 403.01, 403.10, 403.11, 403.90, 403.91, 404.00, 404.01, 404.02, 404.03, 404.10, 404.11, 404.12, 404.13, 404.90, 404.91, 404.92, 404.93, 585.3, 585.4 or 585.5
Link
J0885
Link
Not Stated HCT 30-36% or Hb 10-12 g/dL
Link
Serum creatinine > 2.5, creatinine clearance < 60 mL/min (not required for stage I or II), or GFR < 60 mL/min/1.73m^2 (not required for stage I or II)
Link
Link
Not Stated Not Applicable
Surgery (hip or knee) 285.29 or 285.9 and V07.8
Link
J0885
Link
Hb between 10 and 13 g/dL
Link
Not Stated SC: Not Applicable

GFR: Not Applicable
Not Stated Not Applicable

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call PROCRITline® at 1-800-553-3851 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.
R146
Back to Top



Please refer to the National Coverage Determination (NCD) for additional information that may supercede the Medicare guidelines provided by your local Medicare Carrier, Fiscal Intermediary, or Medicare Administrative Contractor (MAC).



Summary - Part B - Updated July 22, 2010

For additional information on Medicare covered indications for your specific state, please see the appropriate Medicare carrier Part B Local Coverage Determinations/Supporting Documentation which may be accessed through the link above or by
clicking here - Part B.

Indication ICD-9-CM HCPCS Starting Labs Ending Labs GFR/Serum Creatinine Allowable Dosage Post Chemo
Cancer (chemo) 284.89 or 285.3 and V58.11 or V58.12 and 140.0-149.9, 150.0-159.9, 160.0-165.9, 170.0-176.9, 179-189.9, 190.0-199.1, 199.2, 200.00-202.98, 203.00-203.81, 203.82, 204.00-204.91, 204.92, 209.00-209.30, 209.31, 209.32, 209.33, 209.34, 209.35, 209.36, 233.30, 233.31, 233.32, 233.39, 235.0-235.9, 236.0-236.99, 237.0-237.9, 238.0, 238.1, 238.2, 238.3, 238.5, 238.6, 238.77, 238.79-238.9, 239.0-239.8, 239.81, 239.89, 239.9 or 273.3
Link
Link
J0885
Link
Link
HCT < 30% or Hb < 10 g/dL
Link
Link
HCT 30%
Link
Link
SC: Not Applicable

GFR: Not Applicable
Starting dose 150 U/kg 3x/wk.
Link
Link
8 weeks
Link
Link
AIDS/AZT 284.89 and 042 or 079.53
Link
Link
J0885
Link
Link
Not Stated HCT 30-36% or Hb 10-12 g/dL
Link
Link
SC: Not Applicable

GFR: Not Applicable
Not Stated Not Applicable
Renal 285.21 and 403.00, 403.01, 403.10, 403.11, 403.90, 403.91, 404.00, 404.01, 404.02, 404.03, 404.10, 404.11, 404.12, 404.13, 404.90, 404.91, 404.92, 404.93, 585.3, 585.4 or 585.5
Link
Link
J0885
Link
Link
Not Stated HCT 30-36% or Hb 10-12 g/dL
Link
Link
Serum creatinine > 2.5, creatinine clearance < 60 mL/min (not required for stage I or II), or GFR < 60 mL/min/1.73m^2 (not required for stage I or II)
Link
Link
Link
Link
Not Stated Not Applicable
Surgery (hip or knee) 285.29 or 285.9 and V07.8
Link
Link
J0885
Link
Link
Hb between 10 and 13 g/dL
Link
Link
Not Stated SC: Not Applicable

GFR: Not Applicable
Not Stated Not Applicable

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call PROCRITline® at 1-800-553-3851 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.
R145
Back to Top